Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Litwin

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cytometry. Part B, Clinical Cytometry|December 29, 2020
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analysesGhanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, et al.
Cytometry. Part B, Clinical Cytometry|November 14, 2015
Recommendations for the development and validation of flow cytometry-based receptor occupancy assaysCherie L Green, Jennifer J Stewart, Carl-Magnus Högerkorp, et al.
Cytometry. Part B, Clinical Cytometry|December 26, 2015
Role of receptor occupancy assays by flow cytometry in drug developmentJennifer J Stewart, Cherie L Green, Nicholas Jones, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelinesSara A Monaghan, Steven Eck, Silvia Bunting, et al.
Bioanalysis|November 19, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity)Susan Richards, Lakshmi Amaravadi, Renuka Pillutla, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 14, 2019
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2019 Conference WorkshopsKamila Czechowska, Joanne Lannigan, Nima Aghaeepour, et al.
Bioanalysis|November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays)Lauren Stevenson, Susan Richards, Renuka Pillutla, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 18, 2019
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2018 Conference WorkshopsKamila Czechowska, Joanne Lannigan, Lili Wang, et al.
Bioanalysis|December 11, 2019
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)Steven Piccoli, Devangi Mehta, Alessandra Vitaliti, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 31, 2025
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference WorkshopsPaul K Wallace, Evan R Jellison, Sherry Thornton, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cytometry. Part B, Clinical Cytometry|December 29, 2020
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analysesGhanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, et al.
Cytometry. Part B, Clinical Cytometry|November 14, 2015
Recommendations for the development and validation of flow cytometry-based receptor occupancy assaysCherie L Green, Jennifer J Stewart, Carl-Magnus Högerkorp, et al.
Cytometry. Part B, Clinical Cytometry|December 26, 2015
Role of receptor occupancy assays by flow cytometry in drug developmentJennifer J Stewart, Cherie L Green, Nicholas Jones, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelinesSara A Monaghan, Steven Eck, Silvia Bunting, et al.
Bioanalysis|November 19, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity)Susan Richards, Lakshmi Amaravadi, Renuka Pillutla, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 14, 2019
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2019 Conference WorkshopsKamila Czechowska, Joanne Lannigan, Nima Aghaeepour, et al.
Bioanalysis|November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays)Lauren Stevenson, Susan Richards, Renuka Pillutla, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 18, 2019
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2018 Conference WorkshopsKamila Czechowska, Joanne Lannigan, Lili Wang, et al.
Bioanalysis|December 11, 2019
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)Steven Piccoli, Devangi Mehta, Alessandra Vitaliti, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 31, 2025
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference WorkshopsPaul K Wallace, Evan R Jellison, Sherry Thornton, et al.
Pageof 4